Patent details

Basic Information

Publication number:

EP3331494

PCT Application Number:

EP2016068687

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167477777

PCT Publication Number:

WO2017021508

First applicant's nationality:

Translation Language:

EPO Publication Language:

English Title of Invention:

COMPOSITION INTENDED TO VECTORISE AN ANTI-CANCER AGENT

French Title of Invention:

COMPOSITION DESTINÉE À VECTORISER UN AGENT ANTICANCÉREUX

German Title of Invention:

ZUSAMMENSETZUNG ZUR VEKTORISIERUNG EINES KREBSMITTELS

SPC Number:

Dates

Filing date:

04/08/2016

Grant date:

21/04/2021

EP Publication Date:

13/06/2018

PCT Publication Date:

09/02/2017

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

21/04/2021

EP B1 Publication Date:

21/04/2021

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/08/2021

Expiration date:

04/08/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/04/2021

 

 

Name:

Guerbet

Address:

15 Rue des Vanesses, 93420 Villepinte, France (FR)

Inventor

1

Name:

ROBIC, Caroline

Address:

France (FR)

2

Name:

MAYER, Jean-François

Address:

France (FR)

Priority

Priority Number:

1557524

Priority Date:

04/08/2015

Priority Country:

France (FR)

Classification

IPC classification:

A61K 9/00; A61K 47/02; A61K 47/14; A61K 9/107; A61K 47/44; A61K 31/704; A61K 49/04; A61K 49/08; A61K 49/10; A61P 35/00;

Publication

European Patent Bulletin

Issue number:

202116

Publication date:

21/04/2021

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages